Skip to content

A Phase 1 Study to Assess Mass Balance, Pharmacokinetics, and Metabolism of [14C]Subasumstat in Patients With Advanced or Metastatic Solid Tumors

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-503449-79-00
Acronym
TAK-981-1004
Enrollment
6
Registered
2023-09-21
Start date
2023-10-10
Completion date
2024-07-16
Last updated
2024-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced or Metastatic Solid Tumours

Interventions

None listed

Sponsors

Takeda Development Center Americas Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Hungary

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026